NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 69918-0735-10 — Isoproterenol hydrochloride injectionAI (387 hospitals, 51,703–52,972 samples)
• NDC 57237-0077-10 — Ondansetron 4 mg dissolving tabletsAI (654 hospitals, 46,473–52,962 samples)
• NDC 63323-0162-43 — Ketorolac 30 mg/mL injectionAI (163 hospitals, 48,482–52,955 samples)
• NDC 63323-0884-06 — Sodium phosphate oral solutionAI (495 hospitals, 51,370–52,855 samples)
• NDC 00065-0795-50 — Balanced salt solution for use inside the eyeAI (566 hospitals, 51,629–52,817 samples)
• NDC 63323-0461-57 — Bupivacaine with epinephrine local anesthetic injectionAI (504 hospitals, 50,894–52,757 samples)
• NDC 00281-0326-08 — Nitroglycerin ointment 2%AI (1180 hospitals, 51,022–52,741 samples)
• NDC 65219-0257-01 — Ephedrine sulfate injection (50 mg/mL)AI (233 hospitals, 51,616–52,696 samples)
• NDC 63323-0492-97 — Xylocaine 1% injectable solutionAI (568 hospitals, 46,535–52,691 samples)
• NDC 76329-3301-01 — Dextrose 50% injectionAI (356 hospitals, 51,530–52,682 samples)
• NDC 65219-0056-09 — Potassium phosphate intravenous solutionAI (188 hospitals, 50,040–52,650 samples)
• NDC 70756-0605-82 — Verapamil 2.5 mg/mL intravenous injectionAI (190 hospitals, 51,637–52,627 samples)
• NDC 00168-0006-15 — Triamcinolone acetonide 0.1% ointmentAI (596 hospitals, 51,229–52,624 samples)
• NDC 00409-1775-40 — Dextrose 25% intravenous syringeAI (383 hospitals, 51,499–52,597 samples)
• NDC 00143-9392-01 — REMIFENTANIL 2 MG INTRAVENOUS SOLUTIONAI (184 hospitals, 51,948–52,533 samples)
• NDC 00409-4713-12 — Lidocaine 1% injection solutionAI (174 hospitals, 49,196–52,409 samples)
• NDC 08290-3065-44 — Saline flush for intravenous lineAI (139 hospitals, 48,372–52,386 samples)
• NDC 00703-1153-03 — Norepinephrine injection, 4 mL vialAI (248 hospitals, 50,638–52,366 samples)
• NDC 63323-0161-41 — Ketorolac 15 mg/mL injectionAI (117 hospitals, 47,577–52,365 samples)
• NDC 00409-1749-71 — Bupivacaine with epinephrine injection, preservative-freeAI (321 hospitals, 51,278–52,295 samples)
• NDC 63323-0881-01 — Sodium phosphates IV solutionAI (464 hospitals, 50,810–52,286 samples)
• NDC 00264-1965-10 — Hetastarch 6% in saline IV solutionAI (239 hospitals, 50,983–52,198 samples)
• NDC 00143-9595-25 — Lidocaine 1% injection (preservative-free)AI (491 hospitals, 38,564–52,127 samples)
• NDC 76045-0103-20 — Ondansetron 4 mg/2 mL syringeAI (233 hospitals, 50,323–52,087 samples)
• NDC 50484-0010-30 — Collagenase ointment 250 unit per gramAI (1393 hospitals, 50,780–52,040 samples)
• NDC 49502-0102-02 — Epinephrine auto-injector 0.3 mgAI (595 hospitals, 49,103–52,001 samples)
• NDC 72572-0511-40 — Magnesium sulfate premixed in waterAI (21 hospitals, 51,983 samples)
• NDC 55150-0304-01 — Dexamethasone sodium phosphate 10 mg/mL injectionAI (415 hospitals, 45,341–51,965 samples)
• NDC 67457-0475-20 — Vecuronium bromide 20 mg injectionAI (250 hospitals, 51,054–51,909 samples)
• NDC 00781-3220-95 — Rocuronium injection for muscle relaxation during surgeryAI (289 hospitals, 50,744–51,905 samples)
• NDC 44567-0621-24 — Calcium gluconate and sodium chloride IV solutionAI (635 hospitals, 50,778–51,876 samples)
• NDC 71288-0714-10 — Cisatracurium besylate injection, 20 mg/10 mL IVAI (262 hospitals, 50,838–51,837 samples)
• NDC 65219-0257-00 — Ephedrine sulfate injection, 50 mg/mLAI (192 hospitals, 50,838–51,837 samples)
• NDC 00338-0126-12 — Regular human insulin in saline IV solutionAI (1058 hospitals, 47,056–51,835 samples)
• NDC 39822-1220-01 — Neomycin and polymyxin B urinary irrigation solutionAI (202 hospitals, 50,925–51,816 samples)
• NDC 63323-0186-01 — Sodium chloride 0.9% injection, preservative-freeAI (420 hospitals, 46,495–51,814 samples)
• NDC 70860-0776-02 — Ondansetron injection, 4 mg per 2 mL (anti-nausea medicine)AI (351 hospitals, 48,464–51,812 samples)
• NDC 08290-3065-46 — Saline flush syringeAI (297 hospitals, 43,836–51,783 samples)
• NDC 54288-0105-15 — Ethyl alcohol 99% solution for intra-arterial useAI (697 hospitals, 50,303–51,761 samples)
• NDC 76045-0211-20 — Midazolam injection, 1 mg/mL, 2 mL vialAI (29 hospitals, 50,058–51,750 samples)
• NDC 00264-7750-07 — Lactated Ringer's intravenous solutionAI (128 hospitals, 50,705–51,713 samples)
• NDC 00409-3308-03 — Acetylcysteine inhalation solution 20%AI (534 hospitals, 50,744–51,689 samples)
• NDC 63323-0421-02 — Dexmedetomidine sedation medication, IV solutionAI (239 hospitals, 49,707–51,624 samples)
• NDC 00338-0656-04 — ACETIC ACID 0.25 % IRRIGATION SOLUTIONAI (486 hospitals, 50,629–51,592 samples)
• NDC 00409-3307-03 — Acetylcysteine 10% solutionAI (270 hospitals, 50,607–51,561 samples)
• NDC 63323-0170-15 — Sodium phosphate injection solution, intravenousAI (365 hospitals, 51,012–51,561 samples)
• NDC 39822-1201-02 — Neomycin and polymyxin B bladder irrigation solutionAI (303 hospitals, 50,634–51,480 samples)
• NDC 00338-0023-04 — Dextrose 10% intravenous solutionAI (718 hospitals, 47,725–51,478 samples)
• NDC 00781-7516-87 — Budesonide 0.5 mg/2 mL nebulizer suspensionAI (163 hospitals, 50,596–51,451 samples)
• NDC 54288-0105-02 — Ethanol 99% solution, 5 mL ampuleAI (566 hospitals, 50,182–51,451 samples)